Prostaglandin E.sub.2 /F.sub.2.alpha. combination for treating impotence
OwnerNathan Earl Scottinventor
Life of this patent
Estimating the term…
Abstract
Disclosed herein is method of treating and a composition for treating erectile dysfunction in a male patient by administering to the patient a unit dose of a formulation comprising an erectile dysfunction treating amount of a prostaglandin, namely prostaglandin E.sub.1, prostaglandin E.sub.2, or pharmaceutically acceptable salts or derivatives thereof, wherein the prostaglandin is formulated with a small amount of prostaglandin F.sub..alpha.2 together with a pharmaceutically acceptable delivery medium and/or a lubricant.
Claims12
A method of treating erectile dysfunction in a male patient comprising the step of administering to the urethra of said patient a unit dose of a mixture of
- a) PGF.sub.2.alpha., a physiologically acceptable salt thereof, or a physiologically acceptable ester thereof, or a mixture thereof, and
- b) an erectile inducing prostaglandin, said erectile inducing prostaglandin selected from the group consisting of PGE.sub.1, PGE.sub.2, a physiologically acceptable salt thereof, a physiologically acceptable ester thereof, and mixtures thereof,
- the mixture of a) and b) above carried in a readily dispersable pharmaceutically acceptable delivery medium.
A composition for treating erectile dysfunction in a male patient comprising a mixture of
- a) PGF.sub.2.alpha., a physiologically acceptable salt thereof, or a physiologically acceptable ester thereof, or a mixture thereof and
- b) an erectile inducing prostaglandin, said erectile inducing prostaglandin selected from the group consisting of PGE.sub.1, PGE.sub.2, a physiologically acceptable salt thereof, a physiologically acceptable ester thereof, and a mixture thereof,
- the mixture of a) and b) above carried in a readily dispersable pharmaceutically acceptable delivery medium.
Dependencies are inferred from the claim text.